Tumeo will lead the ChemComp project, which was awarded for Exploratory Research in Extreme Scale Science

PNNL data scientist in the Biological Sciences Division won the 2023 JSM Data Challenge Expo. The award-winning analysis focused on the ability to identify crime patterns by correlating them with historical events and trends.

The Rapid Assessment of Platform Technologies to Expedite Response project aims to prepare against future pandemics.

PNNL chemist Christopher Anderton recently named president-elect of the Imaging Mass Spectrometry Society (IMSS). In this new position, he will help lead the merge of IMSS with a European-based society, currently underway.

Bobbie-Jo Webb-Robertson is a leader with a PhD in decision sciences & engineering systems from Rensselaer Polytechnic Institute and experience in managing complex scientific programs and line organizations. She assumed the role 3/13/23.

A paper by PNNL researchers has been chosen as one of 32 NIEHS Papers of the Year—a top 1% honor in the research field.

New research findings published in Science Advances (November 2022), help explain the progression of Alzheimer-related dementia in each patient. The findings outline a biological classification system that predicts disease severity.

We are pleased to welcome 20 new joint appointees to PNNL.

Parallel graph neural networks identify protein-ligand 3-D structural interactions to aid in protein function prediction and drug discovery.

The scientist behind the online cartoon RedPen/BlackPen explains how humor can build bridges between scientists and the public.

Scientists have devised a way to engineer yeast to produce sustainable, eco-friendly commodity chemicals using computing power as a guide.

The nested nanoPOTS chip is the next generation of technology developed at PNNL to prepare single cells for proteomics.

PNNL data scientists are refining their artificial intelligence tools with COVID-19 data to advance therapeutics and treatments for a future pandemic.

PNNL researchers are forming a clearer picture of how plant matter is transformed in the microbial gardens created by leaf-cutter ants.

PNNL computational biologists, structural biologists, and analytical chemists are using their expertise to safely accelerate the design step of the COVID-19 drug discovery process.

Pacific Northwest National Laboratory (PNNL) researchers pioneer a new tool to represent cellular response to viral infection.

Six months into a pandemic that has claimed more than 570,000 lives worldwide, scores of PNNL scientists are engaged in dozens of projects in the fight against COVID-19.

Accurate identification of metabolites, and other small chemicals, in biological and environmental samples has historically fallen short when using traditional methods.